Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma.
Qian WangYibin JiangQian ZhuYishan DuanXiaochen ChenTing XuZhengming JinCaixia LiDepei WuHaiwen HuangPublished in: Journal of cancer research and clinical oncology (2021)
Hepatosplenic γ δ T-cell lacks a standard therapy and is often refractory to conventional chemotherapy regimens. Intensive induction chemotherapy followed by hematopoietic cell transplantation may improve the prognosis of HSTCL.